A new breakthrough is rocking the world of medical science, as researchers at the Ohio State University in America have developed a new nanochip-based technology that can start healing injuries with a single touch.
The technology, also called Tissue Nanotransfection (TNT), has the ability to change the genetic code of any cell to repair damaged tissues, grow organs and even stop ageing!
The Miracle Device
As small as a cufflink, and just as light, the TNT chip can be used immediately by medical professionals without the need for lengthy lab procedures.
The chip just needs to be placed on the affected part of the person's body with a drop of the genetic cargo and then activated with a small electrical charge, which will immediately deliver new DNA and RNA strands to the damaged cells.
This entire process takes less than a second, and the individual does not need to carry the device around with him afterwards. The cargo will just keep working on his cells.
No Need For Immune-suppressants!
Since TNT works by changing the function of the body's own cells, there is no need for immune-suppressants to prevent tissue rejection. The body's immunity will never attack the cells created by this procedure.
Research Team Led By An Indian-Origin Scientist
The team at OSU was jointly led by Dr. Chandan Sen, Director of Regenerative Medicine, and Dr. James Lee, Professor of Chemical and Biomolecular Engineering.
And the initial success of the device was demonstrated on injured mice.
To show the efficacy of the new device, the researchers applied it to injured legs of mice that showed no blood flow under scans.
After 1 week, the area developed new blood vessels, which improved healing on-site and allowed the area to regenerate within 2 weeks.
The team has also tried this technique on mice with stroke-induced brain injuries. The process works just as well on deeper tissues as it does on skin cells, even though the device is only placed on the surface of the body.
A Success Rate of 98%
Till now this new technology has only been tested on mice and pigs. But with a success rate of 98% (something that is rarely seen in the field of medical science), the team now has the green signal to proceed with clinical trials on human volunteers, which they plan to start in 2018.
So until then, we can just wait and watch.
Enjoyed reading this article? Hit the heart button below to show your love.
Image source: OSU Wexner Medical Center